Adv Healthc Mater. 2021 Dec 28. e2102226
Sewoom Baek,
Seung Eun Yu,
Yu-Heng Deng,
Yong-Jae Lee,
Dong Gue Lee,
Surim Kim,
Seonjin Yoon,
Hye-Seon Kim,
Jeongeun Park,
Chan Hee Lee,
Jung Bok Lee,
Hyun Joon Kong,
Seok-Gu Kang,
Young Min Shin,
Hak-Joon Sung.
Glioblastoma is one of the most intractable tumor types due to the progressive drug resistance upon tumor mass expansion. Incremental hypoxia inside the growing tumor mass drives epigenetic drug resistance by activating non-genetic repair of anti-apoptotic DNA, which could be impaired by drug treatment. Hence, rescuing inter-tumor hypoxia by oxygen-generating microparticles may promote susceptibility to anti-tumor drugs. Moreover, a tumor-on-a-chip model a enables user-specified alternation of clinic-derived samples. This study utilized patient-derived glioblastoma tissue to generate cell spheroids with size variations in a 3D microchannel network chip (GBM chip). As the spheroid size increased, epigenetic drug resistance was promoted with inward hypoxia severance, as supported by the spheroid size-proportional expression of hypoxia-inducible factor-1a in the chip. Loading anti-hypoxia microparticles onto the spheroid surface significantly reduced drug resistance by silencing the expression of critical epigenetic factor, resulting in significantly decreased cell invasiveness. The results were confirmed in vitro using cell line and patient samples in the chip as well as chip implantation into a hypoxic hindlimb ischemia model in mice, which is an unprecedented approach in the field. This article is protected by copyright. All rights reserved.
Keywords: 3D glioblastoma chip; drug resistance; epigenetic alteration; hypoxia rescue; oxygen-releasing microparticle